Additionally, patient assistance programs may help reduce out-of-pocket costs
That triple agonism is generating intense interest in pre-clinical metabolic-research circles, where investigators are comparing it head-to-head against the dual agonist Tirzepatide and the GLP-1 mono-agonist Semaglutide
Glucagon like peptide-1 (GLP-1) is a 30 or 31 amino acid long peptide hormone mainly secreted by 3 tissues in the human body: enteroendocrine L cells in the distal intestine, alpha cells in the pancreas, and the central nervous system
This raises major concerns about safety, dosing, and quality control
GLP-1 medications are injectable, once daily or weekly, depending on the formulation
Although research is currently limited, this is what we know so far